Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder-Reference-Cited by-同舟云学术

Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder

Published:2009 Issue: Volume:9999B Page:n/a-n/a
ISSN:1552-4841
Container-title:American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
language:en
Short-container-title:Am. J. Med. Genet.

Author:

Casamassima Francesco,Huang Jie,Fava Maurizio,Sachs Gary S.,Smoller Jordan W.,Cassano Giovanni B.,Lattanzi Lorenzo,Fagerness Jes,Stange Jonathan P.,Perlis Roy H.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Genetics(clinical)

Reference80 articles.

1. A comparison of unipolar and bipolar depressive illness;Abrams;Am J Psychiatry,1980

2. Criteria for the “soft” bipolar spectrum: Treatment implications;Akiskal;Psychopharmacol Bull,1987

3. Cyclothymic disorder: Validating criteria for inclusion in the bipolar affective group;Akiskal;Am J Psychiatry,1977

4. Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors;Akiskal;J Affect Disord,1983

5. Switching from ‘unipolar’ to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients;Akiskal;Arch Gen Psychiatry,1995

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of health-related quality of life among the older adults with and without hypertension: results of a cross-sectional study;Journal of Public Health;2023-09-04

2. A pilot pharmacogenetic study of calcium channel blocker treatment of bipolar mania;Psychiatry Research;2023-08

3. Association between depression and macrovascular disease: a mini review;Frontiers in Psychiatry;2023-06-29

4. Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects;Cardiovascular Research;2022-07-28

5. Calcium Channel Antagonists for Mood Disorders;Journal of Clinical Psychopharmacology;2022-02-21